Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
FTC - completely agree. Great RNS and the start of a news-rich period. GLA holders.
50p / share for core orph after spin offs
The RNS is excellent news, not necessarily for us right now, but it demonstrates in a significant way that development work in 'core ORPH' is progressing as planned and promised, and this particular challenge model could be of great value in the right hands. Makes core ORPH ever more attractive for a sale at some point (not too far away IMHO)
bronx - well the opportunity is there to ask them. Are you joining the event next week? have you prepared your questions in a coherent and concise way - they can be submitted in advance?
The govt has created an approval process which the avacta lft can't pass (PD - frozen samples etc). This deficiency in the approval process has been known for months and govt has done nothing about it.
Yup, I'd label you as all of those kilgeever - can't see that you have contributed anything helpful here, only continuous criticism of the company, its management and those invested.
This Medical Pioneer Is Scooping Contracts and There's New Skin in the Game
Hello, Share Lovers. One of the best indicators of a company that might be going places is when directors have skin in the game. That is: they own a lot of shares. And it’s better still when they’ve very recently bought more. So perhaps it’s time to have another look at a AIM medical pioneer, Open Orphan (ORPH).
clear now your only aim here is to deramp, troll and disrupt. 'not sold a single share' - yeah right, coz you haven't got any.
kilg, bear relentlessly negative. draw your own conclusions - what purpose can it serve?
yawwwwn ... always falling back on this old chestnut. trying v hard to find negatives on a day with 4 good RNSs. Twat ..
kilg - if you wait until all is known and proven it'll all be in the sp and you'll miss out. I think 4 or my 5 'wishes' are stated company plans for the coming months and the 5th is my educated guess which I know a number of others share.
kilg - very wise, and I'm not complaining. CF's putting the time, expertise and personal funds into the entire ORPH project. I'm sitting here watching and contributing nothing else (as I suspect are you) and will get a nice bonus from the Poolbeg shares issued to me. Then ditto from the following spin-offs. Then highly likely cash dividend around Xmas. Plus, through the year likely capital gain as sp increases with core ORPH continuing to expand and win contracts. Then, if not sooner (my expectation) huge boost when offer comes in for core ORPH and / or bidding war. What a great prospect!
Blackrhino1 - agreed. And with chimagents now formally and legally part of core orph it makes the company an even more attractive proposition for the right suitor. Personally still don't think that's too far away.
don't let them win DDB. there are clearly ulterior motives at play. I am sure genuine investors in ORPH appreciate your input and this board will be the worse should you depart.
I agree, its a common issue across the boards - wouldn't be surprised if these people are placed and rewarded for simply disrupting things, perhaps MMs or others need this kind of activity to help stimulate markets, buying, selling etc....
but I agree, intensely annoying!
tricky when there's suddenly such a barrage of negative commentary ...
Blah - what I was expecting from what I heard CF say was that they would make a loss in 2020 but he was aiming for turnaround and a profitable final quarter, which is what we got. He was also looking for a strong start to 2021, which he has also indicated we've got.
ryan - they never intended 2020 to be a profitable year and never said it would be. They have been clear throughout that it was a transition year, and they made absolutely massive strides in that time. That has created the foundation for a hugely cash generative and profitable 2021, and also established the spin off opportunities.
Not difficult to find out. From 14th June RNS: "... Relevant Shareholders will receive one Poolbeg Share for every 2.98 ordinary shares held in the Company [ORPH], with resultant entitlements rounded down to the nearest whole number ..."
The exec officers exercised 700k of share options last week. This sale of 242000 is to pay the tax on those purchases. Nothing to worry about.
jeez! what do you have to do to get a contract terminated by this government?
"The new contract is announced against the backdrop of the NAO review, published on Friday, that found that during a surge in cases in December, only 17 per cent of people received test results in 24 hours, against a target of 90 per cent.
Since the government launched an asymptomatic testing programme in October, 691m lateral flow test kits had been sent out in England but the results of only 14 per cent had been returned.
The NAO also said the test and trace system, which had underspent its budget by £8.7m, still had “low or variable” public compliance, with only a minority of symptomatic people requesting a test or self-isolating."
The CEO of Serco is Rupert Soames, studied PPE at Oxford (as did Matt Han****), brother of former Tory MP Sir Nicholas Soames ...